gr 117289 has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dowle, MD; Hobson, JE; Jack, TI; Judd, DB; Middlemiss, D; Panchal, TA; Pass, M; Ross, BC; Scopes, DI; Tranquillini, E | 1 |
| Drew, GM; Gardner, CJ; Hilditch, A; Hunt, AA; Middlemiss, D; Polley, J; Robertson, MJ; Ross, BC; Travers, A; Twissell, DJ | 1 |
2 other study(ies) available for gr 117289 and Blood Pressure, High
| Article | Year |
|---|---|
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.
Topics: Administration, Oral; Amino Acid Sequence; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzofurans; Biological Availability; Disease Models, Animal; Dogs; Hypertension; In Vitro Techniques; Kinetics; Molecular Sequence Data; Rabbits; Rats; Receptors, Angiotensin; Structure-Activity Relationship | 1994 |
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Callithrix; Dogs; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renovascular; Injections, Intra-Arterial; Male; Nicotinic Acids; Rats; Rats, Inbred SHR; Tetrazoles | 1994 |